Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

(2021) Arnon Nagler et al.   Journal of Hematology & Oncology

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

(2020) Alexandros Spyridonidis et al.   BONE MARROW TRANSPLANTATION

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

(2020) Annie Im et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party

(2020) Eolia Brissot et al.   BONE MARROW TRANSPLANTATION

Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia

(2020) Arnon Nagler et al.   HAEMATOLOGICA

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

(2020) Monzr M. Al Malki et al.   Blood Advances

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

(2020) Jonathan A. Webster et al.   Blood Advances

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy

(2019) Zachariah DeFilipp et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

(2019) Noga Shem-Tov et al.   LEUKEMIA

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

(2018) Partow Kebriaei et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

(2018) Annalisa Ruggeri et al.   Journal of Hematology & Oncology

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

(2018) Sebastian Giebel et al.   BONE MARROW TRANSPLANTATION

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

(2017) Nicole Santoro et al.   Journal of Hematology & Oncology

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study

(2016) Y. Wang et al.   CLINICAL CANCER RESEARCH

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant

(2016) Annalisa Ruggeri et al.   HAEMATOLOGICA

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

(2016) Nicolaus Kröger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant

(2016) Annalisa Ruggeri et al.   HAEMATOLOGICA

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

(2015) A Ruggeri et al.   BONE MARROW TRANSPLANTATION

Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update

(2015) A Bacigalupo et al.   BONE MARROW TRANSPLANTATION

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

(2015) A Ruggeri et al.   LEUKEMIA

Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant

(2013) Celalettin Eroglu et al.   LEUKEMIA & LYMPHOMA

Total body irradiation plus cyclophosphamideversusbusulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis

(2010) Xu Shi-Xia et al.   LEUKEMIA & LYMPHOMA

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

(2009) Jürgen Finke et al.   LANCET ONCOLOGY